Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Uczestniczysz w badaniu WU-PE-CGS
- •Masz zdiagnozowanego raka przewodu żółciowego
- •Masz zdiagnozowanego szpiczaka (jeśli jesteś osobą czarnoskórej rasy)
- •Masz raka jelita grubego (jeśli jesteś osobą czarnoskórej rasy i miałeś co najmniej 65 lat w chwili diagnozy)
- •Masz ukończone 18 lat
- •Rozumiesz dokumenty badania i wyrażasz zgodę na udział
- •Masz dostęp do komputera, tabletu lub telefonu komórkowego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Washington University School of Medicine
St Louis, United States
Trial contact
Erin Linnenbringer, Ph.D., MS
Bettina Drake, Ph.D., MPH
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/22/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.